CONTEXT: Breast cancer is the second largest cause of cancer death among women in the United States. Given the fear associated with its morbidity and mortality, patients might seek a variety of alternative treatments. No careful description of breast cancer patients' interest in or use of these therapies appears to exist. OBJECTIVE: To create a profile that describes interest in and use of a wide variety of alternative therapies available to breast cancer outpatients; to gather data concerning related issues such as the number of appointments for these therapies, their cost, and reimbursement patterns; and to compare these findings with a published profile of the general public. DESIGN: An interview gauging patients' interest in and use of alternative treatments followed by 2 questionnaires concerning (1) mental adjustment to the cancer experience and (2) personal growth in response to the encounter with cancer. SETTING: Suburban breast cancer clinic in a Midwestern university medical center. PARTICIPANTS: 112 female breast cancer outpatients. MAIN OUTCOME MEASURES: Rankings of interest in and use of alternative treatments by the patients interviewed. RESULTS: The 3 most frequently used alternative therapies were prayer (76%), exercise (38%), and spiritual healing (29%). Comparison with the general public profiles revealed that breast cancer patients more frequently used 17 specific alternative therapies. The largest increases were found in the use of prayer (51% increase), spiritual healing (25% increase), and megavitamins (23% increase). Only chiropractic was used substantially more often among the general population. CONCLUSION: Breast cancer outpatients involved in conventional treatment are more likely to use a wide range of alternative therapies than is the general public. It is likely that the mortality and morbidity associated with breast cancer motivates this increased use.
CONTEXT: Breast cancer is the second largest cause of cancer death among women in the United States. Given the fear associated with its morbidity and mortality, patients might seek a variety of alternative treatments. No careful description of breast cancerpatients' interest in or use of these therapies appears to exist. OBJECTIVE: To create a profile that describes interest in and use of a wide variety of alternative therapies available to breast cancer outpatients; to gather data concerning related issues such as the number of appointments for these therapies, their cost, and reimbursement patterns; and to compare these findings with a published profile of the general public. DESIGN: An interview gauging patients' interest in and use of alternative treatments followed by 2 questionnaires concerning (1) mental adjustment to the cancer experience and (2) personal growth in response to the encounter with cancer. SETTING: Suburban breast cancer clinic in a Midwestern university medical center. PARTICIPANTS: 112 female breast cancer outpatients. MAIN OUTCOME MEASURES: Rankings of interest in and use of alternative treatments by the patients interviewed. RESULTS: The 3 most frequently used alternative therapies were prayer (76%), exercise (38%), and spiritual healing (29%). Comparison with the general public profiles revealed that breast cancerpatients more frequently used 17 specific alternative therapies. The largest increases were found in the use of prayer (51% increase), spiritual healing (25% increase), and megavitamins (23% increase). Only chiropractic was used substantially more often among the general population. CONCLUSION:Breast cancer outpatients involved in conventional treatment are more likely to use a wide range of alternative therapies than is the general public. It is likely that the mortality and morbidity associated with breast cancer motivates this increased use.
Authors: Mengyuan Du; Xujuan Yang; James A Hartman; Paul S Cooke; Daniel R Doerge; Young H Ju; William G Helferich Journal: Carcinogenesis Date: 2012-01-20 Impact factor: 4.944
Authors: Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan Journal: Am J Hematol Date: 2009-12 Impact factor: 10.047
Authors: Heather Greenlee; Marilie D Gammon; Page E Abrahamson; Mia M Gaudet; Mary Beth Terry; Dawn L Hershman; Manisha Desai; Susan L Teitelbaum; Alfred I Neugut; Judith S Jacobson Journal: Cancer Date: 2009-07-15 Impact factor: 6.860